CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

86 hedge funds and large institutions have $131M invested in Cascadian Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.1M
Puts
$686K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$644K
27
$588K
28
$584K
29
$541K
30
$519K
31
$502K
32
$420K
33
$419K
34
$324K
35
$318K
36
$316K
37
$257K
38
$230K
39
$198K
40
$189K
41
$176K
42
$171K
43
$162K
44
$156K
45
$155K
46
$154K
47
$153K
48
$150K
49
$112K
50
$106K